Bee Venom as a Potential Antitumor Agent

On November 2 and 3 at Cagliari (IT) and Domusnovas (IT), respectively, the project "A possible development plan for Sulcis-Iglesiente companies: nanotechnologies for the valorization of bee venom as a potential antitumor agent" will be presented.

The project was funded by the Banco di Sardegna Foundation and involves "Domus Api" agricultural company, specialized in honey production and derivatives, the Department of Chemistry and Pharmacy of the University of Sassari, and Nanomater and Kitos Biotech companies. Previous studies have shown the cytotoxic potential of bee venom. The aim of the project is to develop a new formulation that can maximize the effects of poison on cancer cells with minimal effects on normal cells.

Kitos Biotech will evaluate the cytotoxicity of the new formulations on three-dimensional tumor models. Irene Marchesi, CEO of Kitos Biotech, will speak at the conference to illustrate the benefits of 3D cell culture in the study of cancer drugs.

​The study involves subjects of the highest scientific profile with different and complementary skills for the execution of the project itself, and we are happy to have been involved. Moreover, the possibility of contributing to the development of the Sulcis area, in the Sardinia region that welcomed us with open arms, believing in us and our value, fills us with pride.